David Loewenstein, Ph.D., ABPP/CN

Director, Center for Cognitive Neuroscience and Aging
Scientific Advisory Board Member, Evelyn F. McKnight Brain Institute
Professor, Psychiatry and Behavioral Sciences
Department of Psychiatry and Behavioral Sciences
University of Miami, Miller School of Medicine
1695 NW 9th Avenue, Suite 3208G
Miami, FL 33136
Phone: 305-355-7016
Email: dloewenstein@miami.edu
Website: http://psychiatry@med.miami.edu

Dr. David Loewenstein is the Director of the Center for Cognitive Neuroscience and Aging and Professor of Psychiatry and Behavioral Sciences for the University of Miami School of Medicine. He is a board-certified clinical neuropsychologist and Director of the Division of Neuropsychology. Previously, Dr. Loewenstein served as Director of Neuropsychology Laboratories and Research at Mount Sinai Medical Center in Miami Beach, FL and Chief of Psychology for Jackson Memorial Hospital. He has been continuously funded by the National Institutes of Health at the University of Miami for more than 25 years and has brought in over 18 million dollars in Federal and State grants. His work is regularly published in top scientific journals and is considered cutting-edge. Dr. Loewenstein’s laboratory has a long history in the development of innovative cognitive and neuropsychological instruments. Dr. Loewenstein developed the first scale for the direct assessment of functional capacity in Alzheimer’s disease which has been translated into numerous languages. Most recently, Dr. Loewenstein and associates developed the Loewenstein and Acevedo Scales for Semantic Interference and Learning (LASSI-L), a cognitive stress test to address the concern that current neuropsychological measures may not capture the earliest stage of Alzheimer’s disease. The LASSI-L is a sensitive marker of the early manifestations of AD and has been increasingly adapted by other laboratories.